Insider Transactions in Q1 2025 at Iovance Biotherapeutics, Inc. (IOVA)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 03
2025
|
Finckenstein Friedrich Graf Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
33,470
-26.48%
|
$133,880
$4.04 P/Share
|
|
Mar 03
2025
|
Finckenstein Friedrich Graf Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
62,497
+33.09%
|
-
|
|
Mar 03
2025
|
Raj K. Puri Chief Regulatory Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
19,984
-9.28%
|
$79,936
$4.04 P/Share
|
|
Mar 03
2025
|
Raj K. Puri Chief Regulatory Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
59,999
+21.79%
|
-
|
|
Mar 03
2025
|
Frederick G Vogt Interim CEO & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
95,413
-21.44%
|
$381,652
$4.04 P/Share
|
|
Mar 03
2025
|
Frederick G Vogt Interim CEO & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
223,943
+33.47%
|
-
|
|
Mar 03
2025
|
Igor Bilinsky Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
33,302
-27.55%
|
$133,208
$4.04 P/Share
|
|
Mar 03
2025
|
Igor Bilinsky Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
62,106
+33.94%
|
-
|
|
Mar 03
2025
|
Jean Marc Bellemin Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
31,734
-36.09%
|
$126,936
$4.04 P/Share
|
|
Mar 03
2025
|
Jean Marc Bellemin Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
58,590
+39.99%
|
-
|
|
Jan 14
2025
|
Igor Bilinsky Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,578
-2.61%
|
$7,890
$5.89 P/Share
|
|
Jan 14
2025
|
Igor Bilinsky Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,813
+4.45%
|
-
|
|
Jan 14
2025
|
Finckenstein Friedrich Graf Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,578
-2.41%
|
$7,890
$5.89 P/Share
|
|
Jan 14
2025
|
Finckenstein Friedrich Graf Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,813
+4.12%
|
-
|
|
Jan 14
2025
|
Frederick G Vogt Interim CEO & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
9,955
-4.31%
|
$49,775
$5.89 P/Share
|
|
Jan 14
2025
|
Frederick G Vogt Interim CEO & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
20,835
+8.27%
|
-
|